rs35619054
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000518.5(HBB):c.143_146dupATCT(p.Thr51ValfsTer4) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000518.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000205 AC: 3AN: 1461878Hom.: 0 Cov.: 36 AF XY: 0.00000275 AC XY: 2AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
beta Thalassemia Pathogenic:2
Variant summary: HBB c.143_146dupATCT (p.Thr51ValfsX4) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251424 control chromosomes (gnomAD). c.143_146dupATCT [also known as CD 47/48 (+ATCT) and as c.146_147insATCT] has been reported in the literature, in the compound heterozygous and homozygous states, in multiple individuals affected with Beta Thalassemia (e.g. Garewal_1994, Jain_1994, Sharma_2010, Hoppe_2013). These data indicate that the variant is very likely to be associated with disease. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
not provided Pathogenic:2
The HBB c.143_146dup (p.Thr51Valfs*4) frameshift variant alters the translational reading frame of the HBB mRNA and causes the premature termination of HBB protein synthesis. It has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). In the published literature, the variant has been reported in multiple individuals with beta thalassemia (PMID: 8081396 (1994), 8199027 (1994), 7558874 (1995), 20132300 (2010), 23590658 (2013)). Based on the available information, this variant is classified as pathogenic. -
This sequence change creates a premature translational stop signal (p.Thr51Valfs*4) in the HBB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HBB are known to be pathogenic (PMID: 23637309). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with beta thalassemia (PMID: 8081396). This variant is also known as insertion of 4 nucleotides (ATCT) at codon 48, codons 47/48 (+ATCT). ClinVar contains an entry for this variant (Variation ID: 439135). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at